Skip to main content

Advertisement

Table 2 Factor influencing neurological outcomes

From: Neurological outcome of treatment for patients with impending paralysis due to epidural spinal cord compression by metastatic spinal tumor

Factor Parameter p value
Type of treatment PSD 3 (16.7%), PS 2 (13.3%), Rad 10 (18.8%) 0.9642
Male vs. female 9/61 (14.8%) vs. 6/27 (22.2%) 0.3902
Age (years), mean 39–85, 64.4 ± 12.6 0.9956
The level of the spine that exhibited the greatest tumor-related spinal cord compression C1-T2 level 2 (11.8%), T3-L1 level 8 (25.0%), L2-S1 level 5 (12.8%) 0.3539
No. of affected vertebral body, mean 1–8, 3.4 ± 2.3 0.5415
Primary site Lung 7, kidney 3, colon 1, unknown 3, others 1 0.6713
No. of VAS 0 2 (13.3%) 0.2717
Transverse location A 6 (13.3%), AP 3 (15.8%), AF 5 (23.8%), APF 3 (60%) 0.9316
ESCC scale 1b 5 (11.3%), 1c 6 (20.7%), 2 3 (25%), 3 1 (33.3%) 0.1325
Spinal instability neoplastic score 10.5 ± 8.6 (vs. 9.5 ± 5.4) 0.2287
Additional adjuvant therapy No 6/26 (23.1%) 0.3299
Survival period (months), mean 1.5–20, 7.7 ± 6.0 0.4296
Pre-treatment Barthel index, mean 40–100, 89.3 ± 22.4 0.0666
  1. PSD posterior stabilization with decompression, PS posterior stabilization without decompression, VAS visual analog scale score, A anterior lesion, AP anterior + posterior lesion, AF anterior + foraminal lesion, APF anterior + posterior + foraminal lesion, ESCC epidural spinal cord compression, No no additional adjuvant therapy